Article Type
Changed
Fri, 01/18/2019 - 13:38
Display Headline
VIDEO: How to talk to patients about MS drug risks

DALLAS – Patients with multiple sclerosis have likely already heard the worst about their treatment options from the Internet; they need help balancing risks and benefits.

The key is offering them options, knowing what problems need to be discussed, and monitoring treatment beyond what’s usually recommended on product labeling, said Dr. Donna Graves, an MS specialist at the University of Texas Southwestern Medical Center, Dallas. She shared her tips – and also a heads-up about alemtuzumab, which might be approved for MS as soon as this fall – at a meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis.

[email protected]

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Meeting/Event
Author and Disclosure Information

Publications
Topics
Legacy Keywords
multiple sclerosis, treatment options, risks, benefits, monitoring treatment, Dr. Donna Graves, MS, alemtuzumab, Consortium of Multiple Sclerosis Centers, Americas Committee for Treatment and Research in Multiple Sclerosis,
Sections
Author and Disclosure Information

Author and Disclosure Information

Meeting/Event
Meeting/Event

DALLAS – Patients with multiple sclerosis have likely already heard the worst about their treatment options from the Internet; they need help balancing risks and benefits.

The key is offering them options, knowing what problems need to be discussed, and monitoring treatment beyond what’s usually recommended on product labeling, said Dr. Donna Graves, an MS specialist at the University of Texas Southwestern Medical Center, Dallas. She shared her tips – and also a heads-up about alemtuzumab, which might be approved for MS as soon as this fall – at a meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis.

[email protected]

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

DALLAS – Patients with multiple sclerosis have likely already heard the worst about their treatment options from the Internet; they need help balancing risks and benefits.

The key is offering them options, knowing what problems need to be discussed, and monitoring treatment beyond what’s usually recommended on product labeling, said Dr. Donna Graves, an MS specialist at the University of Texas Southwestern Medical Center, Dallas. She shared her tips – and also a heads-up about alemtuzumab, which might be approved for MS as soon as this fall – at a meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis.

[email protected]

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Publications
Publications
Topics
Article Type
Display Headline
VIDEO: How to talk to patients about MS drug risks
Display Headline
VIDEO: How to talk to patients about MS drug risks
Legacy Keywords
multiple sclerosis, treatment options, risks, benefits, monitoring treatment, Dr. Donna Graves, MS, alemtuzumab, Consortium of Multiple Sclerosis Centers, Americas Committee for Treatment and Research in Multiple Sclerosis,
Legacy Keywords
multiple sclerosis, treatment options, risks, benefits, monitoring treatment, Dr. Donna Graves, MS, alemtuzumab, Consortium of Multiple Sclerosis Centers, Americas Committee for Treatment and Research in Multiple Sclerosis,
Sections
Article Source

AT THE CMSC/ACTRIMS ANNUAL MEETING

PURLs Copyright

Inside the Article